New mutations in the mycobacterial ATP synthase: new insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure.
about
Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline.Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerationsAcquired resistance of Mycobacterium tuberculosis to bedaquilineUnexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquilineNew Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in MycobacteriaPhenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery.A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant TuberculosisHalogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery.Bedaquiline Targets the ε Subunit of Mycobacterial F-ATP Synthase.Resistance in tuberculosis: what do we know and where can we go?TMC207 becomes bedaquiline, a new anti-TB drug.Bedaquiline - The first ATP synthase inhibitor against multi drug resistant tuberculosis.The c-Ring of the F1FO-ATP Synthase: Facts and Perspectives.Synthesis and bioactivity of antitubercular peptides and peptidomimetics: an update.Drug Resistance Mechanisms in Mycobacterium tuberculosis.Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complex.Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline.Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex.Design, Synthesis and Characterization of N-oxide-containing Heterocycles with In vivo Sterilizing Antitubercular Activity.After 40 years, new medicine for combating TB.Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST.Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis.Mycobacterial Membrane Proteins QcrB and AtpE: Roles in Energetics, Antibiotic Targets, and Associated Mechanisms of Resistance.Evolution of Phenotypic and Molecular Drug Susceptibility Testing.Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study.Asymmetric Synthesis and Absolute Configuration Assignment of a New Type of Bedaquiline Analogue.Tomatidine, a lead antibiotic molecule that targets Staphylococcus aureus ATP synthase subunit C.Emerging drugs and drug targets against tuberculosis.Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in KoreaCollated data of mutation frequencies and associated genetic variants of bedaquiline, clofazimine and linezolid resistance in
P2860
Q26824413-7E60D33E-3A7F-4C0D-9CAC-F06ABCDE59A5Q27342142-765F718B-0C9C-448A-A321-B3648FDDE7B3Q28072205-947BF051-C417-4603-A52C-245D3092E901Q28540637-BA735AB6-1BCB-4369-855C-EFF81E9A7B0CQ33589758-BBA308FF-D087-4992-9365-B0156C382B45Q33600161-AC38D497-BD86-4997-81FD-0CF57A2F8D03Q33901126-596F3453-9EB9-43D9-BECB-AEA47505396EQ33939074-511905A5-871D-43B8-A704-E4E938F237A4Q35181268-AD409603-CDDE-41F4-AA89-58240EF9E32DQ37358778-EB7C4768-6744-4878-9A03-240A5BE27E96Q38124261-55D514EA-CE73-48D1-B32D-33E62F497884Q38135901-50362F27-2989-43B2-B436-095FE3F597E1Q38190535-E69B1DC7-952D-4AE1-9AA0-673106882B74Q38654199-1683C75A-1A24-4878-A2B9-43B5286A9390Q38662313-2334B7FB-CA2E-4D62-B6F7-C6CEB985AE1FQ38792870-FA46E557-3D8B-4ABD-BE89-77AF9EAAAF3EQ38863350-8C4178E9-30EC-4250-8899-2C136F6E87CBQ38995175-CC063B00-67F6-4898-A594-C681B764CB7DQ39354581-36889665-3EF0-47FE-B10C-C9770B1ED215Q40441723-1E442279-80F1-4832-A5D1-520250C84CA7Q41992338-726B5D87-AF1D-480D-BE61-0F50791B27DBQ42119482-D227A610-590E-4F28-A355-097C0E12CE95Q42430318-CD2C1C18-5BED-4BE6-B28C-D26C71F94BD3Q45198957-5E46AAD4-E888-44BD-B44B-87AC3C567BB5Q47446710-337AF62F-57A4-4DF1-AF8B-0D8244B48F72Q47632774-836ACD0A-5AD3-4FB5-B562-ADC1185D307FQ50033600-7500F656-3138-439B-9ACE-079018900100Q51598159-B6F13473-A1F3-4528-A9FB-DE12AFBEFD06Q52611994-842C43E5-8C4A-4260-AD88-79D7838EA856Q53746587-57DFAEAF-A5B8-4F5F-A316-F8114417F1C8Q57212447-D43CEFAF-B13E-4FBD-83CD-607A4AF11A31Q57299943-C68C8EC7-A353-4F6F-88BF-C59D36E344F5
P2860
New mutations in the mycobacterial ATP synthase: new insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
New mutations in the mycobacte ...... ATP synthase C-ring structure.
@en
type
label
New mutations in the mycobacte ...... ATP synthase C-ring structure.
@en
prefLabel
New mutations in the mycobacte ...... ATP synthase C-ring structure.
@en
P2093
P2860
P356
P1476
New mutations in the mycobacte ...... ATP synthase C-ring structure.
@en
P2093
Aurelie Nevejans-Chauffour
Elena Segala
Vincent Jarlier
P2860
P304
P356
10.1128/AAC.06154-11
P407
P577
2012-02-21T00:00:00Z